BHC
Price
$7.06
Change
-$0.06 (-0.84%)
Updated
Jul 3 closing price
Capitalization
3.86B
25 days until earnings call
TKPHF
Price
$28.35
Change
+$0.67 (+2.42%)
Updated
Jun 24 closing price
Capitalization
47.94B
Interact to see
Advertisement

BHC vs TKPHF

Header iconBHC vs TKPHF Comparison
Open Charts BHC vs TKPHFBanner chart's image
Bausch Health Companies
Price$7.06
Change-$0.06 (-0.84%)
Volume$1.18M
Capitalization3.86B
Takeda Pharmaceutical
Price$28.35
Change+$0.67 (+2.42%)
Volume$245
Capitalization47.94B
BHC vs TKPHF Comparison Chart in %
Loading...
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TKPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BHC vs. TKPHF commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHC is a Buy and TKPHF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (BHC: $7.06 vs. TKPHF: $28.35)
Brand notoriety: BHC: Notable vs. TKPHF: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BHC: 58% vs. TKPHF: 0%
Market capitalization -- BHC: $3.86B vs. TKPHF: $47.94B
BHC [@Pharmaceuticals: Other] is valued at $3.86B. TKPHF’s [@Pharmaceuticals: Other] market capitalization is $47.94B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BHC’s FA Score shows that 0 FA rating(s) are green whileTKPHF’s FA Score has 2 green FA rating(s).

  • BHC’s FA Score: 0 green, 5 red.
  • TKPHF’s FA Score: 2 green, 3 red.
According to our system of comparison, TKPHF is a better buy in the long-term than BHC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BHC’s TA Score shows that 5 TA indicator(s) are bullish while TKPHF’s TA Score has 2 bullish TA indicator(s).

  • BHC’s TA Score: 5 bullish, 3 bearish.
  • TKPHF’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, BHC is a better buy in the short-term than TKPHF.

Price Growth

BHC (@Pharmaceuticals: Other) experienced а +10.14% price change this week, while TKPHF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.13%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +93.03%.

Reported Earning Dates

BHC is expected to report earnings on Jul 30, 2025.

TKPHF is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TKPHF($47.9B) has a higher market cap than BHC($3.86B). TKPHF has higher P/E ratio than BHC: TKPHF (22.47) vs BHC (13.39). TKPHF YTD gains are higher at: 5.981 vs. BHC (-12.407). TKPHF has higher annual earnings (EBITDA): 1.15T vs. BHC (2.2B). TKPHF has more cash in the bank: 369B vs. BHC (947M). BHC has less debt than TKPHF: BHC (22.4B) vs TKPHF (4.75T). TKPHF has higher revenues than BHC: TKPHF (4.11T) vs BHC (8.76B).
BHCTKPHFBHC / TKPHF
Capitalization3.86B47.9B8%
EBITDA2.2B1.15T0%
Gain YTD-12.4075.981-207%
P/E Ratio13.3922.4760%
Revenue8.76B4.11T0%
Total Cash947M369B0%
Total Debt22.4B4.75T0%
FUNDAMENTALS RATINGS
BHC vs TKPHF: Fundamental Ratings
BHC
TKPHF
OUTLOOK RATING
1..100
4850
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
8
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10084
PRICE GROWTH RATING
1..100
3957
P/E GROWTH RATING
1..100
9822
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TKPHF's Valuation (8) in the null industry is in the same range as BHC (35) in the Pharmaceuticals Other industry. This means that TKPHF’s stock grew similarly to BHC’s over the last 12 months.

TKPHF's Profit vs Risk Rating (100) in the null industry is in the same range as BHC (100) in the Pharmaceuticals Other industry. This means that TKPHF’s stock grew similarly to BHC’s over the last 12 months.

TKPHF's SMR Rating (84) in the null industry is in the same range as BHC (100) in the Pharmaceuticals Other industry. This means that TKPHF’s stock grew similarly to BHC’s over the last 12 months.

BHC's Price Growth Rating (39) in the Pharmaceuticals Other industry is in the same range as TKPHF (57) in the null industry. This means that BHC’s stock grew similarly to TKPHF’s over the last 12 months.

TKPHF's P/E Growth Rating (22) in the null industry is significantly better than the same rating for BHC (98) in the Pharmaceuticals Other industry. This means that TKPHF’s stock grew significantly faster than BHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BHCTKPHF
RSI
ODDS (%)
Bearish Trend 3 days ago
68%
Bearish Trend 3 days ago
48%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
48%
Momentum
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
53%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
46%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
47%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
42%
Advances
ODDS (%)
Bullish Trend 4 days ago
74%
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
55%
Aroon
ODDS (%)
Bullish Trend 3 days ago
75%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TKPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AISZX17.080.22
+1.30%
Alger SmallCap Growth Institutional Z-2
JUSQX17.870.16
+0.90%
JPMorgan US Small Company R4
BRSTX14.580.11
+0.76%
MFS Blended Research Small Cap Eq R3
VMCCX53.230.32
+0.60%
Virtus KAR Mid-Cap Core C
JABNX49.070.27
+0.55%
Janus Henderson Balanced N

BHC and

Correlation & Price change

A.I.dvisor tells us that BHC and TLRY have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BHC and TLRY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHC
1D Price
Change %
BHC100%
-0.84%
TLRY - BHC
27%
Poorly correlated
+11.03%
TEVA - BHC
26%
Poorly correlated
-0.23%
ELAN - BHC
25%
Poorly correlated
-0.54%
CRON - BHC
25%
Poorly correlated
+2.00%
OGI - BHC
25%
Poorly correlated
+3.62%
More

TKPHF and

Correlation & Price change

A.I.dvisor tells us that TKPHF and TAK have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TKPHF and TAK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TKPHF
1D Price
Change %
TKPHF100%
N/A
TAK - TKPHF
27%
Poorly correlated
-0.52%
TEVJF - TKPHF
17%
Poorly correlated
N/A
ZTS - TKPHF
16%
Poorly correlated
+0.06%
BHC - TKPHF
15%
Poorly correlated
-0.84%
QNTM - TKPHF
13%
Poorly correlated
-10.96%
More